EPs 7630 improves acute bronchitic symptoms and shortens time to remission. Results of a randomised, double-blind, placebo-controlled, multicentre trial.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/18449849
Conclusion of this study
In conclusion, EPs 7630 is superior to placebo in the treatment of acute bronchitis and leads to faster remission of bronchitis related symptoms.
Supplements analyzed in this study
|
Health conditions analyzed in this study
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
Functions related to this study
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
Body systems related to this study
Immune System |
Nervous System |
Respiratory System |